theophylline has been researched along with Epithelial Ovarian Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L | 1 |
| Cai, S | 1 |
| Han, C | 1 |
| Banerjee, A | 1 |
| Wu, D | 1 |
| Cui, T | 1 |
| Xie, G | 1 |
| Zhang, J | 1 |
| Zhang, X | 1 |
| McLaughlin, E | 1 |
| Yin, M | 1 |
| Backes, FJ | 1 |
| Chakravarti, A | 1 |
| Zheng, Y | 1 |
| Wang, QE | 1 |
1 other study available for theophylline and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2
Topics: Aldehyde Dehydrogenase 1 Family; Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Prot | 2020 |